helping fight amyloidosisThe Research We Benefit
Spotlight: The Hematologic Malignancies Program
Who is amy? is dedicated to
raising money for amyloidosis research.
Contributing to research may lead to improved treatment and
eventually a cure
for amyloidosis and other related diseases.
Who is amy? supports the
Hematologic Malignancies Program at the Mayo Clinic
because they are
a leader in developing advanced treatments for hematologic
malignancies.
Hematologic Malignancies are
cancers of the blood.
This includes amyloidosis, lymphoma, multiple myeloma and
certain types of leukemia.
Members
of the program include nationally and internationally recognized
investigators, su
ch
as
Dr. Morie Gertz.
Dr. Morie
Gertz works closely with amyloidosis patients and oncologists in
Other Research
- Research at the Mayo Clinic
http://www.mayoclinic.org/amyloidosis/research.html - Research at Indiana University
http://www.iupui.edu/~amyloid/